Control of Klebsiella pneumoniae pulmonary infection and immunomodulation by oral treatment with the commensal probiotic Bifidobacterium longum 5(1A)

Klebsiella pneumoniae (Kp) a common cause of pneumonia leads to intense lung injury and mortality that are correlated with infective exacerbations. Probiotics are a class of microorganisms that have immunomodulatory effects to benefit health. We investigated whether the probiotic Bifidobacterium lon...

Full description

Saved in:
Bibliographic Details
Published in:Microbes and infection 2016-03, Vol.18 (3), p.180-189
Main Authors: Vieira, Angélica T, Rocha, Victor M, Tavares, Luciana, Garcia, Cristiana C, Teixeira, Mauro M, Oliveira, Sérgio C, Cassali, Geovanni D, Gamba, Conrado, Martins, Flaviano S, Nicoli, Jacques R
Format: Article
Language:English
Subjects:
Animals
Bacterial Load
Bifidobacterium - immunology
Child
Disease Models, Animal
Humans
Immunomodulation
Klebsiella Infections - therapy
Klebsiella pneumoniae - immunology
Mice, Inbred C57BL
Pneumonia, Bacterial - therapy
Probiotics - administration & dosage
Survival Analysis
Treatment Outcome
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Klebsiella pneumoniae (Kp) a common cause of pneumonia leads to intense lung injury and mortality that are correlated with infective exacerbations. Probiotics are a class of microorganisms that have immunomodulatory effects to benefit health. We investigated whether the probiotic Bifidobacterium longum 5(1A) induces protection in mice against lung infection induced by Kp and the potential involved mechanisms. Kp infection induced secretion of pro-inflammatory cytokines, neutrophil recruitment, significant bacterial load in the lung and 50% lethality. However, treatment with live B. longum 5(1A) induced faster resolution of inflammation associated with an increased production of IL-10, decreased lung damage with significantly reduction of bacterial burden that contributed to rescue 100% of mice from death. We found that these effects could be attributed, at least in part, to activation of the Toll-like receptor (TLR) adapter protein Mal, since B. longum 5(1A) treatment in Mal-deficient infected mice did not show the protection observed in wild type infected mice. Thus, we propose that live B. longum 5(1A) activates TLR-signaling pathway that results in ROS production and protects the host against pneumonia-induced death by finely tuning the inflammatory response and contributing to faster return to lung homeostasis.
ISSN:1769-714X
DOI:10.1016/j.micinf.2015.10.008